Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Covidien plc (COV), Dollar Tree Inc. (DLTR), Sherwin-Williams Co (SHW): Rail-Splitter Capital Management’s New Picks

Page 1 of 2

Rail-Splitter Capital Management, managed by John Croghan and Richard Fradin, recently filed its 13F Form with the U.S. Securities and Exchange Commission, revealing its equity holdings as of the end of the fourth quarter of 2014. During the quarter, the fund acquired nine new positions and reduced its stakes in over 10 stakes. In this article, we will talk about at the three largest new positions held by the hedge fund, which are represented by Covidien plc (NYSE:COV), Dollar Tree Inc. (NASDAQ:DLTR), and Sherwin-Williams Co (NYSE:SHW).

Covidien plc (NYSE:COV)

Rail-Splitter Capital Management was founded in 2002, and is based in Chicago, Illinois. The hedge fund applies a consistent fundamental investment approach and a disciplined investment process that focuses on fundamental research, deep sector experience and valuation discipline.

Covidien plc (NYSE:COV) is one of new positions the fund disclosed in its latest 13F. According to the filling, Rail-Splitter Capital Management holds 121,970 shares of the company, valued at $12.48 million. Covidien plc (NYSE:COV) is a global healthcare company that develops and manufactures healthcare products for clinical and home use. The company has a market cap of more than $47 billion. The company’s stock during one-year period moved up by over 50%, and currently is trading at $103.64, close to its 52 week high of $106.29.

In June, Medtronic Inc. (NYSE: MDT) signed a deal to acquire Covidien plc (NYSE:COV) in a cash-and-stock transaction valued at $93.22 per Covidien share, or a total of about $42.9 billion. Following the completion of the transaction, both companies will be combined under a new entity to be called Medtronic plc. The deal is subject to certain conditions, including approvals by the companies’ shareholders, regulatory clearances in the U.S., the E.U., China and certain other countries.

Rail-Splitter Capital Management sold its entire stake in Medtronic Inc. (NYSE: MDT) during the fourth quarter, according to the filing. Previously, the fund reported holding 139,791 shares of Medtronic Inc. (NYSE: MDT) at the end of third quarter.

Other investors betting big on Covidien plc (NYSE:COV) include Paulson & Co, led by John Paulson, which disclosed ownership of 12.60 million shares of the company, as of the end of the third quarter. Taconic Capital, managed by Frank Brosens, held 9.91 million shares of the company at the end of September 2014.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!